Inhibition of the initiation of HIV-1 reverse transcription by 3′-azido-3′-deoxythymidine -: Comparison with elongation

被引:0
|
作者
Rigourd, M
Lanchy, JM
Le Grice, SFJ
Ehresmann, B
Ehresmann, C
Marquet, R
机构
[1] Inst Biol Mol & Cellulaire, CNRS, UPR 9002, F-67084 Strasbourg, France
[2] NCI, Frederick Canc Res & Dev Ctr, Resistance Mechanisms Lab, NIH, Frederick, MD 21702 USA
关键词
D O I
10.1074/jbc.M003262200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Initiation of human immunodeficiency virus-1 reverse transcription requires formation of a complex containing the viral RNA, primer tRNA(3)(Lys), and reverse transcriptase, Initiation, corresponding to addition of the first six nucleotides to tRNA(3)(Lys), is distinguished from elongation by its high specificity and low efficiency (processivity), Here, we compared the inhibition of initiation and elongation of reverse transcription by 3'-azido-3'-deoxythymidine 5'-triphosphate (AZTTP), the active form of 3'-azido-3'-deoxythymidine. We report the first detailed study of nucleotide binding, discrimination, and pyrophosphorolysis by the authentic initiation complex, We showed that the initiation and elongation complexes bound AZTTP and dTTP with the same affinity, while the polymerization rates were reduced by 148-160-fold during initiation. The pyrophosphorolysis rate of dTTP was reduced by the same extent, indicating that the polymerization equilibrium is the same in the two phases. The efficient unblocking of the 3'-azido-3'-deoxythymidine 5'-monophosphate (AZTMP)-terminated primer by pyrophosphorolysis significantly relieved inhibition of DNA synthesis during elongation in the presence of physiological pyrophosphate concentrations. Remarkably, although pyrophosphorolysis of dTMP and AZTMP were equally efficient during elongation, reverse transcriptase was almost totally unable to unblock the AZTMP-terminated primer during initiation. As a result, inhibition of reverse transcription by AZTTP was more efficient during initiation than elongation of reverse transcription, despite a reduced selectivity of incorporation.
引用
收藏
页码:26944 / 26951
页数:8
相关论文
共 50 条
  • [1] Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistance
    Nikolenko, Galina N.
    Delviks-Frankenberry, Krista A.
    Palmer, Sarah
    Maldarelli, Frank
    Fivash, Matthew J., Jr.
    Coffin, John M.
    Pathak, Vinay K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) : 317 - 322
  • [2] INHIBITION OF 3'AZIDO-3'DEOXYTHYMIDINE-RESISTANT HIV-1 INFECTION BY DEHYDROEPIANDROSTERONE IN-VITRO
    YANG, JY
    SCHWARTZ, A
    HENDERSON, EE
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) : 1424 - 1432
  • [3] Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside lnhibitors
    Cruchaga, C
    Odriozola, L
    Andréola, M
    Tarrago-Litvak, L
    Martínez-Irujo, JJ
    [J]. BIOCHEMISTRY, 2005, 44 (09) : 3535 - 3546
  • [4] INHIBITION OF HIV-1 TRANSMISSION BY INTERFERON AND 3'-AZIDO-3'-DEOXYTHYMIDINE DURING DENOVO INFECTION OF PROMONOCYTIC CELLS
    DUBREUIL, M
    SPORTZA, L
    DADDARIO, M
    LACOSTE, J
    ROOKE, R
    WAINBERG, MA
    HISCOTT, J
    [J]. VIROLOGY, 1990, 179 (01) : 388 - 394
  • [5] INHIBITION OF THE REVERSE-TRANSCRIPTASE FROM HIV BY 3'-AZIDO-3'-DEOXYTHYMIDINE TRIPHOSPHATE AND ITS THREO ANALOG
    VRANG, L
    BAZIN, H
    REMAUD, G
    CHATTOPADHYAYA, J
    OBERG, B
    [J]. ANTIVIRAL RESEARCH, 1987, 7 (03) : 139 - 149
  • [6] SYNTHESIS AND HIV-1 REVERSE-TRANSCRIPTASE INHIBITION PROPERTIES OF 2 NEW METHYLENEPHOSPHONATE ANALOGS OF 3'-AZIDO-3'-DEOXYTHYMIDINE-5'-TRIPHOSPHATE
    LABATAILLE, P
    PELICANO, H
    MAURY, G
    IMBACH, JL
    GOSSELIN, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (20) : 2315 - 2320
  • [7] CONFORMATIONAL PROPERTIES OF 3'-AZIDO-3'DEOXYTHYMIDINE (AZT), AN INHIBITOR OF HIV REVERSE-TRANSCRIPTASE
    HERZYK, P
    BEVERIDGE, A
    NEIDLE, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (03) : 1356 - 1361
  • [8] 3′-azido-3′-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes
    Ren, JS
    Esnouf, RM
    Hopkins, AL
    Jones, EY
    Kirby, I
    Keeling, J
    Ross, CK
    Larder, BA
    Stuart, DI
    Stammers, DK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9518 - 9523
  • [9] COMPARISON OF THE ANTIVIRAL ACTIVITIES OF 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND GOSSYLIC IMINOLACTONE (GIL) AGAINST CLINICAL ISOLATES OF HIV-1
    ROYER, RE
    MILLS, RG
    YOUNG, SA
    JAGT, DLV
    [J]. PHARMACOLOGICAL RESEARCH, 1995, 31 (01) : 49 - 52
  • [10] HUMAN IMMUNODEFICIENCY VIRUS INHIBITION IS PROLONGED BY 3'-AZIDO-3'-DEOXYTHYMIDINE ALTERNATING WITH 2',3'-DIDEOXYCYTIDINE COMPARED WITH 3'-AZIDO-3'-DEOXYTHYMIDINE ALONE
    SPECTOR, SA
    RIPLEY, D
    HSIA, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 920 - 923